| scholarly article | Q13442814 |
| P50 | author | Michael Hallek | Q20752664 |
| Percy A. Knolle | Q42845667 | ||
| Ulrike Protzer | Q47157729 | ||
| Silke Arzberger | Q117254713 | ||
| Marianna Hösel | Q123514901 | ||
| P2093 | author name string | Jörg Kleeff | |
| Hildegard Büning | |||
| Margarete Odenthal | |||
| Sonja Gillen | |||
| Pia Hartmann | |||
| Dirk Stabenow | |||
| Knud Esser | |||
| Hanna Janicki | |||
| Mathias Broxtermann | |||
| P2860 | cites work | Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors | Q24673796 |
| Intrinsic Cellular Defenses against Virus Infection by Antiviral Type I Interferon | Q27490770 | ||
| Clades of Adeno-associated viruses are widely disseminated in human tissues. | Q34193756 | ||
| Recent developments in adeno-associated virus vector technology | Q34775483 | ||
| Immune responses to AAV in clinical trials | Q36990095 | ||
| Immunity to adeno-associated virus vectors in animals and humans: a continued challenge | Q37127246 | ||
| Toll-like receptors and adaptor molecules in liver disease: update | Q37174620 | ||
| Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. | Q37222231 | ||
| The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice | Q37286686 | ||
| Antigen-presenting cell function in the tolerogenic liver environment. | Q37802751 | ||
| Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide | Q39655506 | ||
| Stimulation of toll-like receptor 2 with bleomycin results in cellular activation and secretion of pro-inflammatory cytokines and chemokines | Q40407850 | ||
| Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency | Q40411792 | ||
| Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection | Q43529982 | ||
| Primary human hepatocytes--a valuable tool for investigation of apoptosis and hepatitis B virus infection | Q45723485 | ||
| Influenza a viruses upregulate neutrophil toll-like receptor 2 expression and function | Q46942386 | ||
| Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. | Q64905980 | ||
| Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides | Q81818978 | ||
| Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies | Q83433656 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toll-like receptor | Q408004 |
| P304 | page(s) | 287-297 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors | |
| P478 | volume | 55 |
| Q64069592 | AAV -regulatory sequences are correlated with ocular toxicity |
| Q92876148 | AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer |
| Q42150059 | Adeno-Associated Viral Vectors at the Frontier between Tolerance and Immunity |
| Q64041060 | Adeno-associated Virus (AAV) versus Immune Response |
| Q40285562 | Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors |
| Q31123164 | CD40 activation rescues antiviral CD8⁺ T cells from PD-1-mediated exhaustion. |
| Q33938435 | Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions |
| Q89431352 | Characterization of Pattern Recognition Receptor Expression and Functionality in Liver Primary Cells and Derived Cell Lines |
| Q38993966 | DNA Minicircle Technology Improves Purity of Adeno-associated Viral Vector Preparations |
| Q36086139 | Deciphering Transcriptome and Complex Alternative Splicing Transcripts in Mammary Gland Tissues from Cows Naturally Infected with Staphylococcus aureus Mastitis |
| Q36740271 | Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivo |
| Q59358394 | Double-stranded RNA innate immune response activation from long-term adeno-associated virus vector transduction |
| Q27332309 | Efficient uptake of blood-borne BK and JC polyomavirus-like particles in endothelial cells of liver sinusoids and renal vasa recta |
| Q38898870 | Elastin-like recombinamers with acquired functionalities for gene-delivery applications. |
| Q47554736 | Emerging Issues in AAV-Mediated In Vivo Gene Therapy |
| Q36709834 | Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells. |
| Q91936196 | Engineering the AAV capsid to evade immune responses |
| Q57803544 | Exposure to wild-type AAV drives distinct capsid immunity profiles in humans |
| Q90146080 | Filling Adeno-Associated Virus Capsids: Estimating Success by Cryo-Electron Microscopy |
| Q37127238 | Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders |
| Q42243339 | Hepatitis B virus infection enhances susceptibility toward adeno-associated viral vector transduction in vitro and in vivo. |
| Q94502776 | Human Immune Responses to Adeno-Associated Virus (AAV) Vectors |
| Q39187167 | IL-24 sensitizes tumor cells to TLR3-mediated apoptosis |
| Q92863312 | Immune Response Mechanisms against AAV Vectors in Animal Models |
| Q92851595 | Immune Responses to Viral Gene Therapy Vectors |
| Q36983740 | Immune responses to AAV vectors: overcoming barriers to successful gene therapy |
| Q92301725 | Innate Immune Response Following AAV Administration |
| Q55032301 | Microbiome-Immune Interactions and Liver Disease. |
| Q36142477 | MyD88 signaling in B cells regulates the production of Th1-dependent antibodies to AAV |
| Q36085401 | Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia B. |
| Q40216716 | Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells. |
| Q38191212 | Pre-Clinical Assessment of Immune Responses to Adeno-Associated Virus (AAV) Vectors |
| Q37621530 | Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies |
| Q91707074 | Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here? |
| Q37488165 | Role of gut microbiota in liver diseases |
| Q36756695 | Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 Vectors |
| Q57039821 | Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy |
| Q92345066 | TPP Combined with DGUC as an Economic and Universal Process for Large-Scale Purification of AAV Vectors |
| Q36102645 | The Microbiome and Immune Regulation After Transplantation |
| Q91722683 | The adeno-associated virus rh10 vector is an effective gene transfer system for chronic spinal cord injury |
| Q26777426 | The enteric microbiome in hepatobiliary health and disease |
| Q38053123 | The scavenger endothelial cell: a new player in homeostasis and immunity |
| Q36155013 | The threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing |
| Q28070077 | Toll-like receptors in pathophysiology of liver diseases |
| Q54241222 | Ultrafiltered recombinant AAV8 vector can be safely administered in vivo and efficiently transduces liver. |
| Q35561776 | Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene Transfer |
| Q40073271 | Unraveling the complex story of immune responses to AAV vectors trial after trial |
Search more.